House to FDA: who’s in charge of clinical trial manufacturing?
US politicians have given the NIH and FDA until Friday to answer questions about oversight at a contaminated National Institutes of Health clinical trial manufacturing site.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs